Global ophthalmic device company OptiMedica Corp. has announced that results from a clinical study of its Catalys Precision Laser System were published in the peer-reviewed journal Science Translational Medicine.
Sun Pharma receives FDA approval for generic Tiazac ANDA
Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of once-a-day Tiazac® extended release capsules.
FDA approves Sun Pharma’s generic Clarinex ANDA
Sun Pharmaceutical Industries Ltd. announced that USFDA has granted it an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Schering Plough’s Clarinex® tablets, 5 mg.
Krieger Eye Institute at Sinai Hospital opens new center for treatment of retinal diseases
The Krieger Eye Institute at Sinai Hospital opened a new center for the treatment of retinal diseases in November. The retina is the layer of tissue at the back of the eye that converts images to electrical impulses. These electrical signals are then p…
Laser System Developed At Stanford Shows Promise For Cataract Surgery
STANFORD, Calif. – Imagine trying to cut by hand a perfect circle roughly one-third the size of a penny. Then consider that instead of a sheet of paper, you’re working with a scalpel and a thin, elastic, transparent layer of tissue, which both offers r…
Novel Genetic Mutation That Causes The Most Common Form Of Eye Cancer Discovered
An international, multi-center study has revealed the discovery of a novel oncogene that is associated with uveal melanoma, the most common form of eye cancer. Researchers have isolated an oncogene called GNA11 and have found that it is present in more…